Growth Investors & VC Firms in Switzerland

135 firms in this list, with a median first check of $1.1M. 33 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
OM Omnes Capital AWADJBFD4 people	88🔒	Paris	FR	Seed–Growth	—	+ Add to CRM
NA naturalX Health Ventures MACPSBYC5 people · Leads rounds	88🔒	Karlsruhe	DE	Seed–Late Stage	$3.2M – $5.4M	+ Add to CRM
HF HF Debt ADAPDVFS8 people	88🔒	Hannover	DE	Growth	$4.4M – $16.5M	+ Add to CRM
OL Oltre Impact LALBNLRF8 people	88🔒	Milan	IT	Seed–Late Stage	$2.2M – $8.6M	+ Add to CRM
SI Sirius Venture Partners GmbH FVMBASJS8 people	88🔒	Wiesbaden	DE	Seed–Growth	$540K – $5.4M	+ Add to CRM
DI DIH Deutsche Industrie-Holding GmbH CSCMDTMF6 people	88🔒	Königstein im Taunus	DE	Growth	$540K – $2.2M	+ Add to CRM
AM AM Ventures AS1 person · Leads rounds	88🔒	Starnberg	DE	Seed–Growth	$540K – $3.2M	+ Add to CRM
SK SKion DBJKRHTD11 people	88🔒	Bad Homburg	DE	Growth	—	+ Add to CRM
TA Target Partners BVMKWDSS7 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $3.2M	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL8 people	88🔒	Oxford	GB	Series A–Late Stage	—	+ Add to CRM
TA Tauros Capital NSCNBPMW4 people	88🔒	Vienna	AT	Series A–Growth	$2.2M	+ Add to CRM
ED EDB Investments CGCKCLJO11 people	88🔒	Singapore	SG	Seed–Late Stage	$12M – $400M	+ Add to CRM
PE Persistent MVOSRRKK4 people	88🔒	Nairobi	KE	Pre-Seed–Growth	$250K – $1M	+ Add to CRM
ME Merifin Capital SHCWCTJH5 people	88🔒	Brussels	BE	Seed–Late Stage	$216K – $3.2M	+ Add to CRM
PO Polarix Group MGTBWFJP8 people	88🔒	Luxembourg	LU	Growth	—	+ Add to CRM
BO Boehringer Ingelheim Venture Fund JGAKDHDH7 people	88🔒	Ingelheim am Rhein	DE	Seed–Growth	$16.2M	+ Add to CRM
GA Gamma Capital Partners BF1 person	88🔒	Vienna	AT	Seed–Growth	—	+ Add to CRM
BU Butler Industries EBLPPCWB4 people	88🔒	Paris	FR	Growth–Late Stage	$10.8M – $54M	+ Add to CRM
FR French Partners ÉLNMEL3 people	88🔒	Paris	FR	Seed–Growth	$1.1M – $5.4M	+ Add to CRM
CA Cathay Health MCEDJHMV5 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
AL Alpina Partners NPFS2 people · Leads rounds	88🔒	Munich	DE	Series A–Late Stage	$635K – $2.5M	+ Add to CRM
NG NGN Capital KAACPJKJ5 people	88🔒	New York	US	Series A–Late Stage	—	+ Add to CRM
SY Syngenta Group Ventures DPJLMLSS6 people	88🔒	Durham	US	Seed–Growth	$500K – $5M	+ Add to CRM
MC MCI Capital S.A. HPTC2 people	88🔒	Warsaw	PL	Growth–Late Stage	$27M – $108M	+ Add to CRM

Omnes Capital

ParisSeed–Growth

AWADJBFD4 people

naturalX Health Ventures

KarlsruheSeed–Late Stage$3.2M – $5.4M

MACPSBYC5 people

HF Debt

HannoverGrowth$4.4M – $16.5M

ADAPDVFS8 people

Oltre Impact

MilanSeed–Late Stage$2.2M – $8.6M

LALBNLRF8 people

Sirius Venture Partners GmbH

WiesbadenSeed–Growth$540K – $5.4M

FVMBASJS8 people

DIH Deutsche Industrie-Holding GmbH

Königstein im TaunusGrowth$540K – $2.2M

CSCMDTMF6 people

AM Ventures

StarnbergSeed–Growth$540K – $3.2M

AS1 person

SKion

Bad HomburgGrowth

DBJKRHTD11 people

Target Partners

MunichSeed–Late Stage$1.1M – $3.2M

BVMKWDSS7 people

Rosetta Capital Ltd.

OxfordSeries A–Late Stage

JHKMMFDL8 people

Tauros Capital

ViennaSeries A–Growth$2.2M

NSCNBPMW4 people

EDB Investments

SingaporeSeed–Late Stage$12M – $400M

CGCKCLJO11 people

Persistent

NairobiPre-Seed–Growth$250K – $1M

MVOSRRKK4 people

Merifin Capital

BrusselsSeed–Late Stage$216K – $3.2M

SHCWCTJH5 people

Polarix Group

LuxembourgGrowth

MGTBWFJP8 people

Boehringer Ingelheim Venture Fund

Ingelheim am RheinSeed–Growth$16.2M

JGAKDHDH7 people

Gamma Capital Partners

ViennaSeed–Growth

BF1 person

Butler Industries

ParisGrowth–Late Stage$10.8M – $54M

EBLPPCWB4 people

French Partners

ParisSeed–Growth$1.1M – $5.4M

ÉLNMEL3 people

Cathay Health

San FranciscoSeed–Late Stage

MCEDJHMV5 people

Alpina Partners

MunichSeries A–Late Stage$635K – $2.5M

NPFS2 people

NGN Capital

New YorkSeries A–Late Stage

KAACPJKJ5 people

Syngenta Group Ventures

DurhamSeed–Growth$500K – $5M

DPJLMLSS6 people

MCI Capital S.A.

WarsawGrowth–Late Stage$27M – $108M

HPTC2 people

Data sourced from public filings and firms' own websites — see our methodology.